ReNeuron stem cell therapy shows long-term promise for stroke

A pioneering stem cell treatment for patients disabled by stroke has continued to show long-term promise in a clinical trial, the British biotech company behind the project said on Friday. News that two-year follow-up data from a small Phase I study showed improvements in limb function with no worrying safety issues lifted shares in ReNeuron 10 percent by 0830 EDT. The clinical results were presented at the European Stroke Organisation Conference in Glasgow. The procedure involves injecting ReNeuron's neural stem cells into patients' brains to repair areas damaged by stroke, thereby improving both mental and physical function.



via Health News Headlines - Yahoo News http://ift.tt/1zoxXdb